関連する実験動画
Updated: Jul 9, 2026
11:31
Generation of Recombinant Influenza Virus from Plasmid DNA
Published on: August 3, 2010
1918年の"スペイン風邪"のヘマグルチニン遺伝子の再結合
M J Gibbs1, J S Armstrong, A J Gibbs
1Division of Botany and Zoology, Faculty of Science, Australian National University, Canberra, ACT 2601, Australia. mark.gibbs@anu.edu.au
Science (New York, N.Y.)
|September 8, 2001
まとめ
1918年のパンデミックインフルエンザウイルスのヘマグルチニン遺伝子は,豚とヒトのインフルエンザウイルスの系統の再結合から発生した可能性が高い. この遺伝的イベントは,ウイルスの毒性を変化させることで,パンデミックを引き起こす可能性がある.
科学分野:
- ウイルス学 ウイルス学 ウイルス学
- 遺伝学 遺伝学とは
- エピデミオロジー エピデミオロジー
背景:
- 1918年のパンデミックインフルエンザウイルスの起源と毒性の要因は,まだ完全に理解されていません.
- ウイルスの遺伝子配列の初期比較は,パンデミックの発生に関する限られた洞察を提供した.
研究 の 目的:
- 1918年のインフルエンザウイルスの遺伝子配列を再分析し,その起源と毒性の決定因子を明らかにする.
- 1918年のパンデミックインフルエンザウイルスの発生と病原性における遺伝子再結合の潜在的な役割を調査する.
主な方法:
- 1918年のインフルエンザウイルスおよび関連するインフルエンザ株の遺伝子配列の比較分析.
- 特定ウイルスの遺伝子の進化史と起源を追跡するための系統遺伝分析.
- ヘマグルチニン遺伝子構造とその潜在的な再結合イベントの詳細な調査.
主要な成果:
- 再分析により,重要な毒性因子であるヘマグルチニン遺伝子が再結合によって発生したことが明らかになった.
- 1918年のヘマグルチニンタンパク質の"球体領域"は,豚系インフルエンザウイルスから派生したものである.
- ヘマグルチニンタンパク質の"茎"領域は,ヒトの血統系インフルエンザウイルスから派生しました.
結論:
- ヘマグルチニン遺伝子を含む遺伝的再結合は,おそらく1918年パンデミックの発生前またはその発生時に発生した.
- この再結合イベントは,ウイルスの毒性を大幅に変化させ,パンデミックを誘発する可能性が高い.
- この再結合を理解することで,高度に毒性の高いインフルエンザ株の出現に関する重要な洞察が得られます.
関連する概念動画
00:57Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
00:42Cross-reactivity
Overview
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
02:32Exon Recombination
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Exon shuffling follows “splice frame rules.” Each exon has three reading...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...